nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Breast cancer mortality in Sweden
|
Rosén, M |
|
2002 |
38 |
12 |
p. 1671- 1 p. |
artikel |
2 |
Calendar
|
|
|
2002 |
38 |
12 |
p. I-II nvt p. |
artikel |
3 |
Combined classical and molecular cytogenetic analysis of cancer
|
Teixeira, M.R |
|
2002 |
38 |
12 |
p. 1580-1584 5 p. |
artikel |
4 |
Commentary
|
Green, D.M |
|
2002 |
38 |
12 |
p. 1645-1646 2 p. |
artikel |
5 |
Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma
|
Chan, J.Y.H |
|
2002 |
38 |
12 |
p. 1600-1606 7 p. |
artikel |
6 |
Does the method of detection of breast cancer affect subsequent psychiatric morbidity?
|
Burgess, C.C |
|
2002 |
38 |
12 |
p. 1622-1625 4 p. |
artikel |
7 |
Editorial comment on ‘Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma’ by Hogg and colleagues
|
van den Brekel, M.W.M |
|
2002 |
38 |
12 |
p. 1561-1563 3 p. |
artikel |
8 |
Fertility and progeny
|
Thomson, A.B. |
|
2002 |
38 |
12 |
p. 1634-1644 11 p. |
artikel |
9 |
Forthcoming Papers
|
|
|
2002 |
38 |
12 |
p. x- 1 p. |
artikel |
10 |
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma
|
Hogg, R.P |
|
2002 |
38 |
12 |
p. 1585-1592 8 p. |
artikel |
11 |
Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients
|
Reitsamer, R. |
|
2002 |
38 |
12 |
p. 1607-1610 4 p. |
artikel |
12 |
News…news…news
|
|
|
2002 |
38 |
12 |
p. 1555-1559 5 p. |
artikel |
13 |
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours
|
Crul, M |
|
2002 |
38 |
12 |
p. 1615-1621 7 p. |
artikel |
14 |
Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours
|
Watters, Amanda D |
|
2002 |
38 |
12 |
p. 1593-1599 7 p. |
artikel |
15 |
Reply to “Breast cancer mortality in Sweden”
|
Levi, F |
|
2002 |
38 |
12 |
p. 1672- 1 p. |
artikel |
16 |
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours
|
Vermeulen, P.B. |
|
2002 |
38 |
12 |
p. 1564-1579 16 p. |
artikel |
17 |
Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
|
Rogers, P. |
|
2002 |
38 |
12 |
p. 1653-1660 8 p. |
artikel |
18 |
Structure–activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition
|
Touhey, S |
|
2002 |
38 |
12 |
p. 1661-1670 10 p. |
artikel |
19 |
The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank
|
Bottomley, A |
|
2002 |
38 |
12 |
p. 1611-1614 4 p. |
artikel |
20 |
This issue's topics
|
|
|
2002 |
38 |
12 |
p. ix- 1 p. |
artikel |
21 |
Use of hair colouring products and breast cancer risk
|
Zheng, T |
|
2002 |
38 |
12 |
p. 1647-1652 6 p. |
artikel |
22 |
Vinorelbine in androgen-independent metastatic prostatic carcinoma—a phase II study
|
Morant, R |
|
2002 |
38 |
12 |
p. 1626-1632 7 p. |
artikel |